All News

Pharmaceutical Executive

Sure, industry growth is at "historically low levels," but at least pharma is still growing. The industry's market value should surpass $825 billion in 2010, and forecasted growth was bumped up one percentage point from original estimates.

Pharmaceutical Executive

Pulling off an incredibly fast turnaround, the pharma industry has released a vaccine for the H1N1 virus, bolstering its bottom line with a second flu vaccine and potentially helping millions of people. So why is there such an uproar over whether it's safe?

i1-631731-1408643415735.jpg

Explaining Innovation

Pharmaceutical Executive

Governments and payers don't see that innovation covers everything from invention to building market share. Scant attention is paid to the critical "back end" of the innovation cycle.

i1-631736-1408643402863.jpg

Pharmaceutical Executive

Game-changers can create competitive advantages for pharmaceutical companies and products.

Pharmaceutical Executive

Just months on the job and GSK’s new president of North American Pharmaceuticals Deirdre Connelly is already making her presence known. Her latest move-spearheading an initiative that will boost funding to autonomous CME programs and cut commercial medical education programs. Pharm Exec spoke with Connelly to find out more.

Takeda takes on Europe

Takeda's Dr Erich Brunn tells Pharm Exec Europe why now is the right time for the Japanese giant to get really serious about Europe.